Search Articles

View query in Help articles search

Search Results (1 to 2 of 2 Results)

Download search results: CSV END BibTex RIS


Mobile Health Intervention to Close the Guidelines-To-Practice Gap in Hypertension Treatment: Protocol for the mGlide Randomized Controlled Trial

Mobile Health Intervention to Close the Guidelines-To-Practice Gap in Hypertension Treatment: Protocol for the mGlide Randomized Controlled Trial

Hypertension (HTN), a major risk factor for strokes and heart attacks, is also a significant comorbidity in severe COVID-19 infections [1-3]. Unfortunately, of the estimated 86 million US adults with HTN, 46% (~40 million) have poorly controlled or uncontrolled HTN [4]. Despite widespread recognition of the health risks of HTN, suboptimal treatment of HTN remains a pernicious problem and is marked by disparities [4,5].

Kamakshi Lakshminarayan, Thomas A Murray, Sarah M Westberg, John Connett, Val Overton, John A Nyman, Kathleen A Culhane-Pera, Shannon L Pergament, Paul Drawz, Emily Vollbrecht, Txia Xiong, Susan A Everson-Rose

JMIR Res Protoc 2021;10(1):e25424